
Wilfried E. E. Eberhardt MD
Department of Medical Oncology, West German Cancer Center, Ruhrlandklinik, University of Duisburg-Essen, Essen, GermanyRecent Contributions to PracticeUpdate:
- ASCO: Combination Immunotherapy for First-Line Treatment of Advanced Lung Cancer
- ASCO: Key Presentations on Small-Cell Lung Cancer
- ASCO: Key Presentations on Non-Small Cell Lung Cancer
- Recent Advances in Locally Advanced Lung Cancer
- ESMO: Survival Benefit From TKIs in Lung Cancer
- Immunotherapy Plus Chemo-Radiotherapy for Patients With Locally Advanced Lung Cancer
- Immunotherapy and TKIs in Stage III Lung Cancer
- ESMO 2018: Social and Behavioral Indicators of Lung Cancer Screening
- ESMO 2018: Genomic Landscape in Early Stage Lung Cancer
- Alectinib: A Step Forward in the Second-Line Treatment of ALK+ NSCLC